img

Global Veterinary Genetic Engineering Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Veterinary Genetic Engineering Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Veterinary Genetic Engineering Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Genetic Engineering Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Poultry and Livestock are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Veterinary Genetic Engineering Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Veterinary Genetic Engineering Vaccines key manufacturers include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd. and Yebio Bioengineering Co., Ltd Of Qingdao, etc. Merck, GSK, Sanofi are top 3 players and held % sales share in total in 2022.
Veterinary Genetic Engineering Vaccines can be divided into Genetic Recombinant Vaccine, Recombinant Subunit Vaccines and Genetic Vaccine,, etc. Genetic Recombinant Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Veterinary Genetic Engineering Vaccines is widely used in various fields, such as Poultry, Livestock and Other,, etc. Poultry provides greatest supports to the Veterinary Genetic Engineering Vaccines industry development. In 2022, global % sales of Veterinary Genetic Engineering Vaccines went into Poultry filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Genetic Engineering Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Santé Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.
Segment by Type
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine

Segment by Application


Poultry
Livestock
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Genetic Engineering Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Genetic Engineering Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Genetic Engineering Vaccines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Genetic Engineering Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Genetic Engineering Vaccines introduction, etc. Veterinary Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Veterinary Genetic Engineering Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Veterinary Genetic Engineering Vaccines Market Overview
1.1 Veterinary Genetic Engineering Vaccines Product Overview
1.2 Veterinary Genetic Engineering Vaccines Market Segment by Type
1.2.1 Genetic Recombinant Vaccine
1.2.2 Recombinant Subunit Vaccines
1.2.3 Genetic Vaccine
1.3 Global Veterinary Genetic Engineering Vaccines Market Size by Type
1.3.1 Global Veterinary Genetic Engineering Vaccines Market Size Overview by Type (2024-2034)
1.3.2 Global Veterinary Genetic Engineering Vaccines Historic Market Size Review by Type (2024-2024)
1.3.3 Global Veterinary Genetic Engineering Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Veterinary Genetic Engineering Vaccines Sales Breakdown by Type (2024-2024)
1.4.2 Europe Veterinary Genetic Engineering Vaccines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Veterinary Genetic Engineering Vaccines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Breakdown by Type (2024-2024)
2 Global Veterinary Genetic Engineering Vaccines Market Competition by Company
2.1 Global Top Players by Veterinary Genetic Engineering Vaccines Sales (2024-2024)
2.2 Global Top Players by Veterinary Genetic Engineering Vaccines Revenue (2024-2024)
2.3 Global Top Players by Veterinary Genetic Engineering Vaccines Price (2024-2024)
2.4 Global Top Manufacturers Veterinary Genetic Engineering Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Veterinary Genetic Engineering Vaccines Market Competitive Situation and Trends
2.5.1 Veterinary Genetic Engineering Vaccines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Genetic Engineering Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Genetic Engineering Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Veterinary Genetic Engineering Vaccines Market
2.8 Key Manufacturers Veterinary Genetic Engineering Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Veterinary Genetic Engineering Vaccines Status and Outlook by Region
3.1 Global Veterinary Genetic Engineering Vaccines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Veterinary Genetic Engineering Vaccines Historic Market Size by Region
3.2.1 Global Veterinary Genetic Engineering Vaccines Sales in Volume by Region (2024-2024)
3.2.2 Global Veterinary Genetic Engineering Vaccines Sales in Value by Region (2024-2024)
3.2.3 Global Veterinary Genetic Engineering Vaccines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Veterinary Genetic Engineering Vaccines Forecasted Market Size by Region
3.3.1 Global Veterinary Genetic Engineering Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Veterinary Genetic Engineering Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Veterinary Genetic Engineering Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Veterinary Genetic Engineering Vaccines by Application
4.1 Veterinary Genetic Engineering Vaccines Market Segment by Application
4.1.1 Poultry
4.1.2 Livestock
4.1.3 Other
4.2 Global Veterinary Genetic Engineering Vaccines Market Size by Application
4.2.1 Global Veterinary Genetic Engineering Vaccines Market Size Overview by Application (2024-2034)
4.2.2 Global Veterinary Genetic Engineering Vaccines Historic Market Size Review by Application (2024-2024)
4.2.3 Global Veterinary Genetic Engineering Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Veterinary Genetic Engineering Vaccines Sales Breakdown by Application (2024-2024)
4.3.2 Europe Veterinary Genetic Engineering Vaccines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Veterinary Genetic Engineering Vaccines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Breakdown by Application (2024-2024)
5 North America Veterinary Genetic Engineering Vaccines by Country
5.1 North America Veterinary Genetic Engineering Vaccines Historic Market Size by Country
5.1.1 North America Veterinary Genetic Engineering Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2024)
5.1.3 North America Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2024)
5.2 North America Veterinary Genetic Engineering Vaccines Forecasted Market Size by Country
5.2.1 North America Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2034)
6 Europe Veterinary Genetic Engineering Vaccines by Country
6.1 Europe Veterinary Genetic Engineering Vaccines Historic Market Size by Country
6.1.1 Europe Veterinary Genetic Engineering Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2024)
6.1.3 Europe Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2024)
6.2 Europe Veterinary Genetic Engineering Vaccines Forecasted Market Size by Country
6.2.1 Europe Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Veterinary Genetic Engineering Vaccines by Region
7.1 Asia-Pacific Veterinary Genetic Engineering Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Veterinary Genetic Engineering Vaccines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Veterinary Genetic Engineering Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales in Value by Region (2024-2034)
8 Latin America Veterinary Genetic Engineering Vaccines by Country
8.1 Latin America Veterinary Genetic Engineering Vaccines Historic Market Size by Country
8.1.1 Latin America Veterinary Genetic Engineering Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2024)
8.1.3 Latin America Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2024)
8.2 Latin America Veterinary Genetic Engineering Vaccines Forecasted Market Size by Country
8.2.1 Latin America Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Veterinary Genetic Engineering Vaccines by Country
9.1 Middle East and Africa Veterinary Genetic Engineering Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Veterinary Genetic Engineering Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Veterinary Genetic Engineering Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck Veterinary Genetic Engineering Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 GSK Veterinary Genetic Engineering Vaccines Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Sanofi Veterinary Genetic Engineering Vaccines Products Offered
10.3.5 Sanofi Recent Development
10.4 Zoties
10.4.1 Zoties Company Information
10.4.2 Zoties Introduction and Business Overview
10.4.3 Zoties Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Zoties Veterinary Genetic Engineering Vaccines Products Offered
10.4.5 Zoties Recent Development
10.5 Elanco
10.5.1 Elanco Company Information
10.5.2 Elanco Introduction and Business Overview
10.5.3 Elanco Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Elanco Veterinary Genetic Engineering Vaccines Products Offered
10.5.5 Elanco Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Indian Immunologicals
10.7.1 Indian Immunologicals Company Information
10.7.2 Indian Immunologicals Introduction and Business Overview
10.7.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Indian Immunologicals Veterinary Genetic Engineering Vaccines Products Offered
10.7.5 Indian Immunologicals Recent Development
10.8 China Animal Husbandry Industry Co.,Ltd.
10.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
10.8.2 China Animal Husbandry Industry Co.,Ltd. Introduction and Business Overview
10.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.8.4 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Products Offered
10.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Development
10.9 Yebio Bioengineering Co., Ltd Of Qingdao
10.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
10.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Introduction and Business Overview
10.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Products Offered
10.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Development
10.10 Jinyu Bio-technology Co.,ltd.
10.10.1 Jinyu Bio-technology Co.,ltd. Company Information
10.10.2 Jinyu Bio-technology Co.,ltd. Introduction and Business Overview
10.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Products Offered
10.10.5 Jinyu Bio-technology Co.,ltd. Recent Development
10.11 HVRI
10.11.1 HVRI Company Information
10.11.2 HVRI Introduction and Business Overview
10.11.3 HVRI Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.11.4 HVRI Veterinary Genetic Engineering Vaccines Products Offered
10.11.5 HVRI Recent Development
10.12 Ringpu Biology
10.12.1 Ringpu Biology Company Information
10.12.2 Ringpu Biology Introduction and Business Overview
10.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Ringpu Biology Veterinary Genetic Engineering Vaccines Products Offered
10.12.5 Ringpu Biology Recent Development
10.13 Kyoto Biken Laboratories
10.13.1 Kyoto Biken Laboratories Company Information
10.13.2 Kyoto Biken Laboratories Introduction and Business Overview
10.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Products Offered
10.13.5 Kyoto Biken Laboratories Recent Development
10.14 FATRO
10.14.1 FATRO Company Information
10.14.2 FATRO Introduction and Business Overview
10.14.3 FATRO Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.14.4 FATRO Veterinary Genetic Engineering Vaccines Products Offered
10.14.5 FATRO Recent Development
10.15 Ceva Santé Animale
10.15.1 Ceva Santé Animale Company Information
10.15.2 Ceva Santé Animale Introduction and Business Overview
10.15.3 Ceva Santé Animale Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Ceva Santé Animale Veterinary Genetic Engineering Vaccines Products Offered
10.15.5 Ceva Santé Animale Recent Development
10.16 Pulike Biological Engineering,Inc.
10.16.1 Pulike Biological Engineering,Inc. Company Information
10.16.2 Pulike Biological Engineering,Inc. Introduction and Business Overview
10.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Products Offered
10.16.5 Pulike Biological Engineering,Inc. Recent Development
10.17 Wuhan Hvsen Biotechnology CO.,LTD
10.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
10.17.2 Wuhan Hvsen Biotechnology CO.,LTD Introduction and Business Overview
10.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Products Offered
10.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Development
10.18 Jinhe Biotechnology Co., Ltd.
10.18.1 Jinhe Biotechnology Co., Ltd. Company Information
10.18.2 Jinhe Biotechnology Co., Ltd. Introduction and Business Overview
10.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Products Offered
10.18.5 Jinhe Biotechnology Co., Ltd. Recent Development
10.19 Shanghai Shen Lian Biomedical Corporation
10.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
10.19.2 Shanghai Shen Lian Biomedical Corporation Introduction and Business Overview
10.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Products Offered
10.19.5 Shanghai Shen Lian Biomedical Corporation Recent Development
10.20 Qingdao Vland Biotech INC.
10.20.1 Qingdao Vland Biotech INC. Company Information
10.20.2 Qingdao Vland Biotech INC. Introduction and Business Overview
10.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Products Offered
10.20.5 Qingdao Vland Biotech INC. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Veterinary Genetic Engineering Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Veterinary Genetic Engineering Vaccines Industrial Chain Analysis
11.4 Veterinary Genetic Engineering Vaccines Market Dynamics
11.4.1 Veterinary Genetic Engineering Vaccines Industry Trends
11.4.2 Veterinary Genetic Engineering Vaccines Market Drivers
11.4.3 Veterinary Genetic Engineering Vaccines Market Challenges
11.4.4 Veterinary Genetic Engineering Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Veterinary Genetic Engineering Vaccines Distributors
12.3 Veterinary Genetic Engineering Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Genetic Recombinant Vaccine
Table 2. Major Company of Recombinant Subunit Vaccines
Table 3. Major Company of Genetic Vaccine
Table 4. Global Veterinary Genetic Engineering Vaccines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (K Units)
Table 6. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (US& Million)
Table 8. Global Veterinary Genetic Engineering Vaccines Market Share in Value by Type (2024-2024)
Table 9. Global Veterinary Genetic Engineering Vaccines Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Veterinary Genetic Engineering Vaccines Sales by Type (2024-2034) & (K Units)
Table 11. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Veterinary Genetic Engineering Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global Veterinary Genetic Engineering Vaccines Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (K Units)
Table 16. North America Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2024-2024)
Table 18. Europe Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2024-2024)
Table 22. Latin America Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Veterinary Genetic Engineering Vaccines Sales by Company (2024-2024) & (K Units)
Table 26. Global Veterinary Genetic Engineering Vaccines Sales Share by Company (2024-2024)
Table 27. Global Veterinary Genetic Engineering Vaccines Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Veterinary Genetic Engineering Vaccines Revenue Share by Company (2024-2024)
Table 29. Global Market Veterinary Genetic Engineering Vaccines Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Veterinary Genetic Engineering Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Veterinary Genetic Engineering Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Genetic Engineering Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into Veterinary Genetic Engineering Vaccines Market
Table 34. Key Manufacturers Veterinary Genetic Engineering Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Veterinary Genetic Engineering Vaccines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Veterinary Genetic Engineering Vaccines Sales by Region (2024-2024) & (K Units)
Table 38. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Veterinary Genetic Engineering Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Region (2024-2024)
Table 41. Global Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Veterinary Genetic Engineering Vaccines Sales by Region (2024-2034) & (K Units)
Table 43. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Veterinary Genetic Engineering Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Veterinary Genetic Engineering Vaccines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) & (K Units)
Table 49. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Application (2024-2024)
Table 52. Global Veterinary Genetic Engineering Vaccines Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Veterinary Genetic Engineering Vaccines Sales by Application (2024-2034) & (K Units)
Table 54. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Veterinary Genetic Engineering Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global Veterinary Genetic Engineering Vaccines Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) (K Units)
Table 59. North America Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) (K Units)
Table 61. Europe Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) (K Units)
Table 65. Latin America Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (K Units)
Table 69. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2024)
Table 72. North America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (K Units)
Table 73. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (K Units)
Table 77. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (K Units)
Table 81. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Merck Company Information
Table 109. Merck Introduction and Business Overview
Table 110. Merck Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Merck Veterinary Genetic Engineering Vaccines Product
Table 112. Merck Recent Development
Table 113. GSK Company Information
Table 114. GSK Introduction and Business Overview
Table 115. GSK Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. GSK Veterinary Genetic Engineering Vaccines Product
Table 117. GSK Recent Development
Table 118. Sanofi Company Information
Table 119. Sanofi Introduction and Business Overview
Table 120. Sanofi Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Sanofi Veterinary Genetic Engineering Vaccines Product
Table 122. Sanofi Recent Development
Table 123. Zoties Company Information
Table 124. Zoties Introduction and Business Overview
Table 125. Zoties Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Zoties Veterinary Genetic Engineering Vaccines Product
Table 127. Zoties Recent Development
Table 128. Elanco Company Information
Table 129. Elanco Introduction and Business Overview
Table 130. Elanco Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Elanco Veterinary Genetic Engineering Vaccines Product
Table 132. Elanco Recent Development
Table 133. Boehringer Ingelheim Company Information
Table 134. Boehringer Ingelheim Introduction and Business Overview
Table 135. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product
Table 137. Boehringer Ingelheim Recent Development
Table 138. Indian Immunologicals Company Information
Table 139. Indian Immunologicals Introduction and Business Overview
Table 140. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product
Table 142. Indian Immunologicals Recent Development
Table 143. China Animal Husbandry Industry Co.,Ltd. Company Information
Table 144. China Animal Husbandry Industry Co.,Ltd. Introduction and Business Overview
Table 145. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product
Table 147. China Animal Husbandry Industry Co.,Ltd. Recent Development
Table 148. Yebio Bioengineering Co., Ltd Of Qingdao Company Information
Table 149. Yebio Bioengineering Co., Ltd Of Qingdao Introduction and Business Overview
Table 150. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product
Table 152. Yebio Bioengineering Co., Ltd Of Qingdao Recent Development
Table 153. Jinyu Bio-technology Co.,ltd. Company Information
Table 154. Jinyu Bio-technology Co.,ltd. Introduction and Business Overview
Table 155. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product
Table 157. Jinyu Bio-technology Co.,ltd. Recent Development
Table 158. HVRI Company Information
Table 159. HVRI Introduction and Business Overview
Table 160. HVRI Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. HVRI Veterinary Genetic Engineering Vaccines Product
Table 162. HVRI Recent Development
Table 163. Ringpu Biology Company Information
Table 164. Ringpu Biology Introduction and Business Overview
Table 165. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 166. Ringpu Biology Veterinary Genetic Engineering Vaccines Product
Table 167. Ringpu Biology Recent Development
Table 168. Kyoto Biken Laboratories Company Information
Table 169. Kyoto Biken Laboratories Introduction and Business Overview
Table 170. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 171. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product
Table 172. Kyoto Biken Laboratories Recent Development
Table 173. FATRO Company Information
Table 174. FATRO Introduction and Business Overview
Table 175. FATRO Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 176. FATRO Veterinary Genetic Engineering Vaccines Product
Table 177. FATRO Recent Development
Table 178. Ceva Santé Animale Company Information
Table 179. Ceva Santé Animale Introduction and Business Overview
Table 180. Ceva Santé Animale Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 181. Ceva Santé Animale Veterinary Genetic Engineering Vaccines Product
Table 182. Ceva Santé Animale Recent Development
Table 183. Pulike Biological Engineering,Inc. Company Information
Table 184. Pulike Biological Engineering,Inc. Introduction and Business Overview
Table 185. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 186. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product
Table 187. Pulike Biological Engineering,Inc. Recent Development
Table 188. Wuhan Hvsen Biotechnology CO.,LTD Company Information
Table 189. Wuhan Hvsen Biotechnology CO.,LTD Introduction and Business Overview
Table 190. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 191. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product
Table 192. Wuhan Hvsen Biotechnology CO.,LTD Recent Development
Table 193. Jinhe Biotechnology Co., Ltd. Company Information
Table 194. Jinhe Biotechnology Co., Ltd. Introduction and Business Overview
Table 195. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 196. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product
Table 197. Jinhe Biotechnology Co., Ltd. Recent Development
Table 198. Shanghai Shen Lian Biomedical Corporation Company Information
Table 199. Shanghai Shen Lian Biomedical Corporation Introduction and Business Overview
Table 200. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 201. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product
Table 202. Shanghai Shen Lian Biomedical Corporation Recent Development
Table 203. Qingdao Vland Biotech INC. Company Information
Table 204. Qingdao Vland Biotech INC. Introduction and Business Overview
Table 205. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 206. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product
Table 207. Qingdao Vland Biotech INC. Recent Development
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Veterinary Genetic Engineering Vaccines Market Trends
Table 211. Veterinary Genetic Engineering Vaccines Market Drivers
Table 212. Veterinary Genetic Engineering Vaccines Market Challenges
Table 213. Veterinary Genetic Engineering Vaccines Market Restraints
Table 214. Veterinary Genetic Engineering Vaccines Distributors List
Table 215. Veterinary Genetic Engineering Vaccines Downstream Customers
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Genetic Engineering Vaccines Product Picture
Figure 2. Global Veterinary Genetic Engineering Vaccines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Veterinary Genetic Engineering Vaccines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Veterinary Genetic Engineering Vaccines Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Genetic Recombinant Vaccine
Figure 6. Global Genetic Recombinant Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Recombinant Subunit Vaccines
Figure 8. Global Recombinant Subunit Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Genetic Vaccine
Figure 10. Global Genetic Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Veterinary Genetic Engineering Vaccines Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Genetic Engineering Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Genetic Engineering Vaccines Revenue in 2022
Figure 25. Veterinary Genetic Engineering Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Poultry
Figure 27. Global Poultry Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Livestock
Figure 29. Global Livestock Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Veterinary Genetic Engineering Vaccines Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application in 2022 & 2034
Figure 34. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. North America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Europe Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Veterinary Genetic Engineering Vaccines Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Veterinary Genetic Engineering Vaccines Manufacturing Cost Structure
Figure 45. Veterinary Genetic Engineering Vaccines Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed